Renaissance Technologies
BTCY

Renaissance Technologies’s Biotricity, Inc. Common Stock BTCY Stock Holding History

Renaissance Technologies’s Portfolio BTCY Stock Details BTCY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-2,002
Closed -$6K – 4363
2023
Q1 		$6K Buy
+2,002
New +$8.22K ﹤0.01% 3910

Other funds holding BTCY

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
SFCL
Strengthening Families & Communities LLC Boston, Massachusetts $401M AUM 33.17% 1-Year Est. Return
AWM
AE Wealth Management Topeka, Kansas $18.5B AUM 19.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
TWC
TD Waterhouse Canada Toronto, Ontario, Canada $38B AUM 39.14% 1-Year Est. Return
SWMP
Signature Wealth Management Partners Montvale, New Jersey $214M AUM 27.04% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return

Renaissance Technologies's BTCY Position: Q2 2023 in Review

Renaissance Technologies sold out of Biotricity, Inc. Common Stock (BTCY) in Q2 2023, closing a stake of 2,002 shares — an estimated $6K sold.

Renaissance Technologies first reported a position in BTCY in Q1 2023 and held it in 1 quarter. The position peaked at $6K in Q1 2023. 23 funds tracked by Wall St. Rank hold BTCY as of Q2 2023.

  • Renaissance Technologies reported no remaining Biotricity, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
  • Renaissance Technologies sold 2,002 Biotricity, Inc. Common Stock shares in Q2 2023, an estimated $6K.
  • Renaissance Technologies first reported a position in Biotricity, Inc. Common Stock in Q1 2023 and held it in 1 quarter.
  • Renaissance Technologies's Biotricity, Inc. Common Stock position peaked at $6K in Q1 2023.
  • 23 funds tracked by Wall St. Rank held Biotricity, Inc. Common Stock as of Q2 2023.

Based on Renaissance Technologies's 13F filing for Q2 2023, filed 11 Aug 2023.